Efficacy and safety of alogliptin versus acarbose in Chinese type 2 diabetes patients with high cardiovascular risk or coronary heart disease treated with aspirin and inadequately...

por Gao, Bin, Gao, Weiguo, Wan, Hailong, Xu, Fengmei, Zhou, Rong, Zhang, Xia, Ji, Qiuhe
Publicado 2022

Effect of Baseline Characteristics on Hypoglycaemia Risk with Insulin Glargine 100 U/mL: Post Hoc Analysis of the BEYOND 7 Study

por Wan, Hailong, Wen, Binhong, Wang, Xueying, Wang, Junfen, Zhang, Yunliang, Ning, Tao, Duan, Binhong, Li, Yufang, Feng, Wei, Zhang, Xia, Cui, Nan, Ji, Linong
Publicado 2021

Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: Results of a multicentre, open‐label, randomized con...

por Ji, Linong, Wan, Hailong, Wen, Binhong, Wang, Xueying, Wang, Junfen, Bian, Rongwen, Pang, Wuyan, Tian, Jian, Wang, Yan, Bian, Fang, Gao, Zhengnan, Condoleon, Alex, Feng, Wei, Zhang, Xia, Cui, Nan
Publicado 2020

Efficacy and safety of a basal insulin + 2‐3 oral antihyperglycaemic drugs regimen versus a twice‐daily premixed insulin + metformin regimen after short‐term intensive insulin ther...

por Pan, Qi, Li, Yijun, Wan, Hailong, Wang, Junfen, Xu, Binhua, Wang, Guoping, Jiang, Chengxia, Liang, Li, Feng, Wei, Liu, Jingcheng, Wang, Ting, Zhang, Xia, Cui, Nan, Mu, Yiming, Guo, Lixin
Publicado 2022